Seeking Alpha
 

PDI, Inc. (PDII)

- NASDAQ
  • Tue, Mar. 3, 4:23 PM
    • PDI (NASDAQ:PDII): Q4 EPS of -$0.30 beats by $0.20.
    • Revenue of $28.91M (-19.4% Y/Y) misses by $0.17M.
    • Press Release
    | Comment!
  • Nov. 3, 2014, 6:23 AM
    • PDI (NASDAQ:PDII): Q3 EPS of -$0.29 misses by $0.10.
    • Revenue of $29.25M (-14.6% Y/Y) misses by $4.19M.
    • Press Release
    | Comment!
  • Aug. 13, 2014, 4:21 PM
    • PDI (NASDAQ:PDII): Q2 EPS of -$0.17 misses by $0.05.
    • Revenue of $31.6M (-15.1% Y/Y) misses by $3.97M.
    • Shares -3.2%.
    • Press Release
    | Comment!
  • Feb. 27, 2014, 5:29 PM
    • PDI, Inc. (PDII): Q4 EPS of -$0.25 misses by $0.14.
    • Revenue of $36.4M misses by $1.71M.
    • Press Release
    | Comment!
  • Aug. 5, 2013, 6:05 PM
    • PDI, Inc (PDII): Q2 EPS of -$0.06 beats by $0.05.
    • Revenue of $37.2M beats by $1.94M. (PR)
    | Comment!
  • May. 13, 2013, 8:39 PM
    More on PDI (PDII): Shares are soaring in the post session after posting a Q1 EPS report that blew away Street estimates. Its bottom-line EPS leapt 800% from the same quarter last year, as total sales grew by 36% over the same period. Operating income swung to a profit on the quarter, largely due to cost cutting efforts and the signing of a $17M multi-year sales contract for which PDII will provide a dedicated team to promote a CNS therapeutic product to neurologists and pain specialists. Shares +30% AH.
    | Comment!
  • May. 13, 2013, 4:16 PM
    PDI, Inc. (PDII): Q1 EPS of $0.14 beats by $0.25. Revenue of $42.9M beats by $4.9M. (PR)
    | Comment!
  • Mar. 6, 2013, 4:50 PM
    PDI, Inc (PDII): Q4 EPS of -$1.64. Revenue of $35.6M misses by $1.3M. (PR)
    | Comment!
Visit Seeking Alpha's
PDII vs. ETF Alternatives
Company Description
PDI Incprovides pharmaceutical, biotechnology, diagnostics and healthcare companies with full-service outsourced product commercialization and promotion solutions through its Commercial Services segment.
Sector: Services
Country: United States